Drug
Interferon Gamma clinical trials
Includes 39 studies of Interferon gamma-1b.
- studies test it
- 65
- open now
- 3
- in phase 3
- 16
- first study started
- 1992
Keep track of what changes. Save the Interferon Gamma studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
62 studies that test it; most in 2001 (5)
| Year | Studies |
|---|---|
| 1992 | 3 |
| 1994 | 1 |
| 1999 | 3 |
| 2000 | 3 |
| 2001 | 5 |
| 2002 | 3 |
| 2003 | 5 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 4 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 3
- Phase 1
- 18
- Phase 2
- 33
- Phase 3
- 16
- Phase 4
- 2
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 24 · Other 41
InterMune (13) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · SPP Pharmaclon Ltd. (5) · Amgen (4) · National Eye Institute (NEI) (4) · National Cancer Institute (NCI) (4) · Radboud University Medical Center (1) · Sawa Ito, MD (1)
Often tested with
Tested in the same studies.
Granulocyte-Macrophage Colony-Stimulating Factor (2) · Ribavirin (2) · Pembrolizumab (1) · Paclitaxel (1) · Trastuzumab (1) · Nivolumab (1) · Carboplatin (1) · Interferon alpha-2 (1)
Studies
Open first, then newest update. How each study uses Interferon Gamma is read from its arms, and is right about nine times in ten.
Testing it · 65
- Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket TrialRecruitingPhase 2Assistance Publique - Hôpitaux de ParisNCT06381661Written as Interferon gamma-1b
- Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU PatientsRecruitingPhase 3Hospices Civils de LyonNCT05843786Written as Interferon gamma
- Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppressionRecruitingPhase 3University Hospital, LimogesNCT06774235Written as Interferon Gamma 1-b
- Safety and Efficacy of Interferon-Gamma 1b in Patients With CandidemiaCompletedPhase 2Radboud University Medical CenterNCT04979052Written as Interferon Gamma-1B
- Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerTerminatedPhase 1National Cancer Institute (NCI)NCT02948426Written as Autologous Monocytes + ACTIMMUNE + SYLATRON
- IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell TransplantationCompletedEarly Phase 1Sawa Ito, MDNCT04628338Written as IFN-γ (interferon gamma-1b) injection
- Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's AtaxiaCompletedPhase 3AmgenNCT02415127Written as Interferon γ-1b
- Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia StudyCompletedPhase 3AmgenNCT02593773Written as Interferon γ-1b
- Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's AtaxiaCompletedPhase 3AmgenNCT02797080Written as interferon γ-1b
- ACTIMMUNE in Intermediate OsteopetrosisCompletedPhase 2Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterNCT02666768Written as Interferon gamma-1b
- Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19CompletedNot applicableSPP Pharmaclon Ltd.NCT05054114Written as Interferon gamma human recombinant (IFN-G)
- Topical Interferon Gamma-1b for Central Serous ChorioretinopathyCompletedPhase 1/2National Eye Institute (NEI)NCT01468337Written as Interferon gamma-1b
- Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and TuberculosisCompletedPhase 1/2SPP Pharmaclon Ltd.NCT05065905Written as Interferon-Gamma
- Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial SarcomaCompletedPhase 2National Cancer Institute (NCI)NCT03063632Written as Interferon Gamma-1b
- Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast CancerCompletedPhase 1/2H. Lee Moffitt Cancer Center and Research InstituteNCT03112590Written as Interferon-gamma (IFN-γ)
- Study of Ingaron's Effect on Efficacy and Resistance to Antibiotics in Community-acquired PneumoniaCompletedNot applicableSPP Pharmaclon Ltd.NCT05395702Written as Interferon-Gamma
- Efficiency and Safety of the Drug Ingaron (Interferon-gamma Human Recombinant) in the Treatment of Chronic ProstatitisCompletedPhase 3SPP Pharmaclon Ltd.NCT05378646Written as Interferon gamma human recombinant (IFN-G)
- Human Recombinant Interferon Gamma-1b for the Prevention of Hospital-acquired Pneumonia in Critically Ill Patients: a Double-blind, International, Phase 2, Randomized, Placebo-controlled Trial - the PREV-HAP StudyStatus unknownPhase 2Nantes University HospitalNCT04793568Written as Recombinant Interferon gamma 1b (IMUKIN®)
- Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital WartsCompletedPhase 3SPP Pharmaclon Ltd.NCT05156541Written as Interferon gamma human recombinant (IFN-G)
- Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected ChildrenCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000761Written as Interferon gamma-1b
See all 65 studies that test Interferon Gamma →
Given in every arm · 5 — Interferon Gamma is usual care beside what is tested
- Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell TransplantationRecruitingPhase 2Sawa Ito, MDNCT06529731Written as Interferon gamma-1b
- Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell CancerTerminatedPhase 1/2Fred Hutchinson Cancer CenterNCT03747484Written as Interferon Gamma-1b
- Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal CancerTerminatedPhase 1/2National Cancer Institute (NCI)NCT00002796Written as recombinant interferon gamma
- Tumor Vaccine and Interferon Gamma in Treating Patients With Refractory Epithelial Ovarian CancerCompletedPhase 1National Cancer Institute (NCI)NCT00004032Written as recombinant interferon gamma
- Study of Gamma Interfereon in Metastatic Colorectal CarcinomaCompletedPhase 2Accelerated Community Oncology Research NetworkNCT00786643Written as Gamma-Interferon-1b (IFN-γ)
Codes
What other systems call Interferon Gamma · ClinicalTrials.gg INT007670
- MeSH (NLM) D007371Interferon-gammaOne source ClinicalTrials.gov
- UNII (FDA) P050J5FWC5INTERFERON GAMMAOne source FDA
- NCI Thesaurus C583Recombinant Interferon GammaOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007371 | Interferon-gamma | One source ClinicalTrials.gov |
| UNII (FDA) | P050J5FWC5 | INTERFERON GAMMA | One source FDA |
| NCI Thesaurus | C583 | Recombinant Interferon Gamma | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.